Bedogni GR - Search Results

1

Conformational analysis and spectroscopic properties of antichagasic nifurtimox.

Gross IP, Lima AL, Bedogni GR, Sa-Barreto L, Gratieri T, Gelfuso GM, Salomon CJ, Cunha-Filho M. Gross IP, et al. Among authors: bedogni gr. Spectrochim Acta A Mol Biomol Spectrosc. 2024 Aug 5;316:124346. doi: 10.1016/j.saa.2024.124346. Epub 2024 Apr 26. Spectrochim Acta A Mol Biomol Spectrosc. 2024. PMID: 38692105

2

Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review.

Arrúa EC, Seremeta KP, Bedogni GR, Okulik NB, Salomon CJ. Arrúa EC, et al. Among authors: bedogni gr. Acta Trop. 2019 Oct;198:105080. doi: 10.1016/j.actatropica.2019.105080. Epub 2019 Jul 9. Acta Trop. 2019. PMID: 31299283 Free article. Review.

3

Elucidating the Splitting Behavior of Tablets to Optimize the Pharmacotherapy in Veterinary Medicine.

Bedogni GR, Pires FQ, Chaker JA, Sa-Barreto LL, Seremeta K, Okulik N, Salomon CJ, Cunha-Filho M. Bedogni GR, et al. AAPS PharmSciTech. 2021 Feb 7;22(2):67. doi: 10.1208/s12249-021-01937-8. AAPS PharmSciTech. 2021. PMID: 33554316

4

Preformulation and Long-Term Stability Studies of an Optimized Palatable Praziquantel Ethanol-Free Solution for Pediatric Delivery.

Bedogni G, Garcia P, Seremeta K, Okulik N, Salomon C. Bedogni G, et al. Pharmaceutics. 2023 Jul 30;15(8):2050. doi: 10.3390/pharmaceutics15082050. Pharmaceutics. 2023. PMID: 37631264 Free PMC article.

5

Melt crystallization and thermal degradation profile of the antichagasic drug nifurtimox.

Gross IP, Lima AL, Bedogni GR, Sa-Barreto L, Gratieri T, Gelfuso GM, Salomon CJ, Cunha-Filho M. Gross IP, et al. Among authors: bedogni gr. J Pharm Biomed Anal. 2024 Feb 15;239:115878. doi: 10.1016/j.jpba.2023.115878. Epub 2023 Nov 28. J Pharm Biomed Anal. 2024. PMID: 38039869

6

Exploring the Dissolution, Solid-state Properties, and Long-term Storage Stability of Cryoprotectant-free Fenbendazole Nanoparticles.

Bedogni G, Michelena LV, Seremeta K, Okulik N, Salomon C. Bedogni G, et al. AAPS PharmSciTech. 2024 Aug 28;25(7):199. doi: 10.1208/s12249-024-02921-8. AAPS PharmSciTech. 2024. PMID: 39198340

7

Formulation and optimization of chitosan-based amorphous fenbendazole microparticles through a design of experiment approach.

Vargas Michelena L, Bedogni GR, Jara MO, Williams RO 3rd, Salomon CJ. Vargas Michelena L, et al. Among authors: bedogni gr. Int J Pharm. 2024 Oct 28;667(Pt A):124872. doi: 10.1016/j.ijpharm.2024.124872. Online ahead of print. Int J Pharm. 2024. PMID: 39490787

8

Nanoformulated fenbendazole as an attractive approach for treating neurocysticercosis: In vitro and in vivo studies.

da Silva YB, Bedogni G, de Andrade Picanço G, de Souza JY, Nunes WS, da Costa TL, de Campos GB, Vargas Michelena L, Salomon CJ, Vinaud MC. da Silva YB, et al. Pharm Dev Technol. 2024 Nov 7:1-13. doi: 10.1080/10837450.2024.2422936. Online ahead of print. Pharm Dev Technol. 2024. PMID: 39508398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters